Paul Tudor Jones Edwards Lifesciences Corp Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 167,146 shares of EW stock, worth $12.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

167,146

Previous 2,900 5663.66%

Holding current value

$12.4 Million

Previous $267,000 4030.71%

% of portfolio

0.04%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $9.98 Million - $15.7 Million	167,146 New	167,146 $11 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $13.9 Million - $17.5 Million	225,527 New	225,527 $17.2 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $10.4 Million - $12 Million	127,545 New	127,545 $12 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $4.4 Million - $5.64 Million	64,460 Added 1526.76%	68,682 $5.12 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $347,766 - $452,978	4,222 New	4,222 $349,000
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $4.04 Million - $4.96 Million	37,937 New	37,937 $4.92 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $3.74 Million - $4.67 Million	-44,600 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $2.32 Million - $2.67 Million	29,453 Added 194.45%	44,600 $3.73 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $533,230 - $678,568	7,438 Added 96.48%	15,147 $1.38 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $870,312 - $1.13 Million	-12,953 Reduced 62.69%	7,709 $615,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.01 Million - $1.36 Million	17,634 Added 582.36%	20,662 $1.43 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $2.58 Million - $3.99 Million	-49,297 Reduced 94.21%	3,028 $571,000
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $3.43 Million - $3.93 Million	47,823 Added 1062.26%	52,325 $12.2 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $277,098 - $339,585	4,502 New	4,502 $990,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $828,836 - $1 Million	-19,525 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $1.11 Million - $1.42 Million	-29,845 Reduced 60.45%	19,525 $2.72 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $775,243 - $903,724	22,943 Added 86.82%	49,370 $5.56 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $959,035 - $1.03 Million	26,427	26,427 $2.89 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account